The Latest Breaking News from the Food and Drug Administration

With the Food and Drug Administration’s Aug. 21, 2023, approval of the first vaccine against respiratory syncytial virus, or RSV, for use during late pregnancy, the U.S. will soon have a major new tool at its disposal to protect infants against the highly contagious virus.

The Food and Drug Administration has approved the first vaccine for expectant mothers to shield their babies from RSV.

The Food and Drug Administration (FDA) approved a drug to help protect infants from respiratory syncytial virus (RSV). The medication, given as a single-dose injection prior to or during RSV season, is a monoclonal antibody. It is intended for babies born during or entering their first RSV season and for…

The Food and Drug Administration’s July 13, 2023, approval of the first over-the-counter birth control pill, called Opill, broadens the options for people seeking to prevent pregnancy. When Opill becomes available, presumably in the first quarter of 2024, it will be sold in grocery and convenience stores, in pharmacies and…

The World Health Organization's cancer research arm deemed aspartame as possibly carcinogenic to humans, but the Food and Drug Administration doesn't agree.

Opill becomes the first hormonal birth control pill in the United States to be approved for over-the-counter sale by the Food and Drug Administration.

The Food and Drug Administration on Thursday approved Opill, making it the nation’s first over-the-counter birth control pill.

The influencer-backed energy drink Prime is popular among children but lawmakers and health experts are concerned over its potentially dangerous levels of caffeine.

The Food and Drug Administration (FDA) has approved the much awaited drug Leqembi which has been shown to slow the cognitive decline caused by Alzheimer’s, the most common type of dementia